TickerFacts.

Minerva Neurosciences, Inc. (NERV): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$5.4K
Year ended 2025-12-31
2023-12-31: $5.4K2024-12-31: $5.4K2025-12-31: $5.4K$5.4K
2023-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$5.4K0.0%2026-03-11, From 2025-01-01
2024-12-31$5.4K0.0%2026-03-11, From 2024-01-01
2023-12-31$5.4Kn/a2025-02-25, From 2023-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Minerva Neurosciences, Inc. (NERV)2025-12-31$5.4K0.0%
Eton Pharmaceuticals, Inc. (ETON)2025-12-31$4.04M+252.9%
Tenax Therapeutics, Inc. (TENX)2024-12-31$0-100.0%
Pyxis Oncology, Inc. (PYXS)2025-12-31$4.51M+51.3%
Aytu Biopharma, Inc (AYTU)2026-06-30$3.93M-26.9%
Shattuck Labs, Inc. (STTK)2025-12-31$3.70M-2.6%
Celularity Inc (CELU)2025-12-31$7.29M-7.9%
Rezolute, Inc. (RZLT)2026-06-30$31.0K0.0%
Milestone Pharmaceuticals Inc. (MIST)2025-12-31$114.0K+8.6%

Compare NERV, ETON, TENX, PYXS side by side · Screen every company in Pharmaceutical Preparations ↗